Italia markets open in 4 hours 53 minutes

Dow Jones
39.872,99
+66,22(+0,17%)
Nasdaq
16.832,62
+37,75(+0,22%)
Nikkei 225
38.700,93
-246,00(-0,63%)
EUR/USD
1,0865
+0,0006(+0,05%)
Bitcoin EUR
64.695,51
-701,31(-1,07%)
CMC Crypto 200
1.523,85
+35,31(+2,37%)

NVCR Jul 2024 22.500 call

OPR - OPR Prezzo differito. Valuta in USD.

Aggiungi a watchlist

2,7200

-1,0300

(-27,47%)

In data: 03:26PM EDT. Mercato aperto.

GlobeNewswire
Zai Lab and Novocure Announce LUNAR Phase 3 Clinical Trial Demonstrates Statistically Significant and Clinically Meaningful Extension in Overall Survival for Patients with Metastatic Non-Small Cell Lung Cancer After Platinum-Based Therapies
Tumor Treating Fields therapy together with standard of care provided a statistically significant and clinically meaningful 3-month improvement in median overall survival versus standard of care with no added systemic toxicities Tumor Treating Fields therapy together with immune checkpoint inhibitors resulted in an unprecedented 8-month improvement in median overall survival LUNAR is the first phase 3 clinical trial in more than seven years to show a significant extension in overall survival in